University Hospital Earns 'Blue Distinction' for Excellence in Cardiac Care
CINCINNATIUniversity Hospital has received designation as a Blue Distinction Center for Cardiac Care from Anthem Blue Cross Blue Shield.
Blue Distinction is awarded to medical facilities that have demonstrated expertise in delivering quality health care and is founded on evidence-based, objective selection criteria in collaboration with expert physicians and medical organizations recommendations.
Kathleen Beal, director of quality management services at University Hospital, says the hospitals cardiac program showed tremendous strength and received high scores in both inpatient and outpatient care in addition to cardiac catheterization services offered.
We are very pleased to have received this distinction, she says. This speaks to the tremendous cardiac care we offer here and allows others to see that this truly is a center of excellence.
The distinction will be placed on the Anthem Blue Cross Blue Shield Web site for patientsand potential patientsto see.
Neal Weintraub, MD, chief of the cardiovascular disease division, says this distinction is another way to showcase the impactful work UC and hospital cardiologists are doing.
Our team is nationally and internationally known for its expertise in both our clinical and emergency heart care, he says. Our doctors bring substantial expertise to the table and ensure that our services are of the highest quality. This distinction, which recognizes all of our hard work, is an honor.
To visit the Anthem Blue Cross Blue Shield Distinction Web site, click here.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.